The number of U.S. adults with severe obesity increased from 2013 to 2023, according to a research letter published online Feb. 13 in the Journal of the American Medical Association.

While some orthopedic and spine surgeons are divided on how medications used for weight loss, including Ozempic and Wegovy, will shape the field, it is undeniable that the drugs are playing an ...

Avery developed osteoporosis after taking Ozempic for about a year without a doctor's supervision. She originally sought the ...

Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

MrBeast - whose real name is Jimmy Donaldson - has opened up about his health condition in a new episode of Steven Bartlett's ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Her weight loss journey of more than 40 kg in one year has gone viral, demonstrating that hard work and moderation, not ...

The Withings Body Scan is available to buy now for a recommended retail price of £349.95/ $425/ AU$692 from Withings and ...

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...